Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib

J Clin Oncol. 2005 Jun 1;23(16):3855-6; author reply 3857-8. doi: 10.1200/JCO.2005.05.246.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / chemistry*
  • Piperazines / pharmacokinetics*
  • Piperazines / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / chemistry*
  • Pyrimidines / pharmacokinetics*
  • Pyrimidines / therapeutic use
  • Tissue Distribution

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases